Prisca Obi
Virtus Therapeutics
Affiliations
Yale University
Technologies
Therapeutic
Indication
Neurodegenerative Disease
Orphan Diseases
Executive Summary
View/DownloadWebsite
virtustherapeutics.comVirtus Therapeutics is pioneering a new class of activator compounds indicated to treat over twenty rare metabolic diseases, including pantothenate kinase-associated neurodegeneration (PKAN) and propionic acidemia.
Program of
Initiated by
